Outcomes after liver transplantation using deceased after circulatory death donors: A comparison of outcomes in the UK and the US
Authors:
- Tommy IvanicsTITommy Ivanics
- Marco P. A. W. ClaasenMCMarco P. A. W. Claasen
- Madhukar S. PatelMPMadhukar S. Patel
- Emmanouil GiorgakisEmmanouil Giorgakis
- Shirin E. KhorsandiSKShirin E. Khorsandi
- Parthi SrinivasanPSParthi Srinivasan
- Andreas PrachaliasAPAndreas Prachalias
- Krishna MenonKMKrishna Menon
- Wayel JassemWJWayel Jassem
- Miriam CortesMCMiriam Cortes
- Blayne A. SayedBSBlayne A. Sayed
- Amit K. MathurAMAmit K. Mathur
- 16 February 2023
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 43 (5) , 1107-1119
Abstract
Background and Aims: Identifying international differences in utilization and outcomes of liver transplantation (LT) after donation after circulatory death (DCD) donation provides a unique opportunity for benchmarking and population‐level insight.Methods: Adult (≥18 years) LT data between 2008 and 2018 from the UK and US were used to assess mortality and graft failure after DCD LT. We used time‐dependent Cox‐regression methods to estimate hazard ratios (HR) for risk‐adjusted short‐term (0–90 days) and longer‐term (90 days–5 years) outcomes.Results: One‐thousand five‐hundred‐and‐sixty LT receipts from the UK and 3426 from the US were included. Over the study period, the use of DCD livers increased from 15.7% to 23.9% in the UK compared to 5.1% to 7.6% in the US. In the UK, DCD donors were older (UK:51 vs. US:33 years) with longer cold ischaemia time (UK: 437 vs. US: 333 min). Recipients in the US had higher Model for End‐stage Liver Disease (MELD) scores, higher body mass index, higher proportions of ascites, encephalopathy, diabetes and previous abdominal surgeries. No difference in the risk‐adjusted short‐term mortality or graft failure was observed between the countries. In the longer‐term (90 days–5 years), the UK had lower mortality and graft failure (adj.mortality HR:UK: 0.63 (95% CI: 0.49–0.80); graft failure HR: UK: 0.72, 95% CI: 0.58–0.91). The cumulative incidence of retransplantation was higher in the UK (5 years: UK: 11.9% vs. 4.6%; p < .001).Conclusions: For those receiving a DCD LT, longer‐term post‐transplant outcomes in the UK are superior to the US, however, significant differences in recipient illness, graft quality and access to retransplantation were seen between the two countries.Keywords
This publication has 40 references indexed in Scilit:
- Big Data in Organ Transplantation: Registries and Administrative ClaimsAmerican Journal of Transplantation, 2014
- Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USAThe Lancet, 2014
- Elective Liver Transplant List Mortality: Development of a United Kingdom End-Stage Liver Disease ScoreTransplantation, 2011
- Events in Procurement as Risk Factors for Ischemic Cholangiopathy in Liver Transplantation Using Donation After Cardiac Death DonorsLiver Transplantation, 2011
- Multiple imputation using chained equations: Issues and guidance for practiceStatistics in Medicine, 2010
- Survival after liver transplantation in the United Kingdom and Ireland compared with the United StatesGut, 2007
- Parsimonious analysis of time‐dependent effects in the Cox modelStatistics in Medicine, 2006
- Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS databaseLiver Transplantation, 2004
- Association of Center Volume with Outcome After Liver and Kidney TransplantationAmerican Journal of Transplantation, 2004
- Transplant data: sources, collection, and caveatsAmerican Journal of Transplantation, 2004